id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-032544-2yrqjw1o	Haroon, Sabrina-Wong-Peixin	Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial	2020-09-04		.txt	text/plain	5232	276	41	title: Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): A study protocol for a randomized controlled trial DISCUSSION: Evidence of successful regression or retardation of vascular calcification will support the conduct of larger and longer-term trials aimed at reducing cardiovascular disease mortality and major adverse cardiovascular events in this high-risk population using a safe and inexpensive strategy TRIAL REGISTRATION: ClinicalTrials.gov NCT02870829. [27] A recent randomized trial reporting 1-year outcome of vitamin K2 supplementation in hemodialysis patients found no effect on aortic calcification despite reduction in dp-ucMGP. The proposed "Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K" (Trevasc-HDK) study is therefore timely. Our trial is important even if the study is negative as we will have more insight into the baseline level and role of vitamin Kin Asian patients as well as provide us with the magnitude and progression of calcification in our multiethnic HD population. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial	./cache/cord-032544-2yrqjw1o.txt	./txt/cord-032544-2yrqjw1o.txt